Health Management

As immunotherapy breaks through in cancer therapy, here are five things to know about this promising treatment.

As we look to the next year we can expect to see a few of these challenges settle, while others will continue to make headlines. Here are three things healthcare executives should watch.

In these arrangements, drug companies must partially reimburse insurers if the drug fails to earn its keep. Will COPD drugs be included in such arrangements?

Here are ways healthcare providers could improve online ratings and better connect with their customers.

Frail patients are a  forgotten patient group-here’s how they were left behind and what can be done about it.

The value and benefits of biosimilars are increasingly becoming more apparent. Here are four areas where they are growing the most.

Here is the one surprising thing that improves patients’ ability to effectively manage their own health.

As President Trump intensifies his battle with German Chancellor Angela Merkel over trade and NATO policies, he should pause to consider the lessons from another German Chancellor-Otto von Bismarck.

How Froedtert Hospital achieves success with a 24/7/365 cancer clinic.

How continuous glucose monitors work, how doctors prescribe them, and whether payers are covering them.

A chief executive officer must have a more diverse team to address the rising complexity and velocity of healthcare. Here are four positions that managed care organizations may want to seriously consider.

It can be tricky for individuals with this condition to effectively tackle their diabetes. Here’s how healthcare executives can help.

Patients must first get over these hurdles to achieve healthy outcomes. Here's how you can help.

Preventable hospital readmissions, an objective measure of quality, have long been a concern for health plans. Here’s a care plan that could be the solution.

Healthcare stakeholders can impact a patient’s health by leveraging available capabilities and resources to help achieve better health outcomes and address this opioid epidemic.

Dealing with cancer is challenging enough for patients and providers. But even when their different perspectives are factored in, that’s not the whole story.

This evidence-based training program can help communities better understand how to connect, not correct, individuals who may be struggling with mental health issues.

It can be challenging for patients with schizophrenia to keep to a medication regimen-here are the reasons why it’s important to invest in strategies to help them stay compliant.

No longer a technology for science fiction, artificial intelligence and machine learning offer the multifaceted approach that healthcare is waiting for.

A survey from insuranceQuotes.com has surprising findings about open enrollment and the ACA.

Managing psoriasis can be difficult for a variety of reasons. Here’s a look at the top six challenges that experts identified.

Philadelphia has the purest and cheapest heroin in the country and a long history of multigenerational heroin addicted families. Here’s what Independence Blue Cross is doing about it.

A Wamberg Genomic Advisors’ Cancer Survey has revealing findings from people dealing directly with cancer.

As lymphoma treatments become less cookie-cutter and more custom, the Leukemia & Lymphoma Society Chief Medical Officer Gwen Nichols, MD, shares how healthcare executives need to alter their approach to managing therapy regimens to increase cure rates and survivorship.

The ability of an oncology practice to succeed in the OCM varies depending on this key factor, according to Avalere research.

With healthcare being a key issue in the midterm elections, here are 11 things healthcare executives should keep in mind.

The launch of a new connected health platform will aid in management of diseases such as diabetes.

New cancer drugs continue to offer patients hope. Here are eight of them.

This year has been another year full of oncology approvals, proving that the oncology pipeline is robust with first-of-the kind molecules, competitor products for existing agents, and biosimilars.

What these healthcare industry disruptors are, and how they could impact cost and quality of care.